Point-of-care testing in diabetes management

1. International Diabetes Federation Diabetes Atlas, Eighth edition. 2017. http://diabetesatlas.org/resources/2017-atlas.htmlSearch in Google Scholar

2. American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27. DOI: 10.2337/dc18-S00210.2337/dc18-S00229222373Open DOISearch in Google Scholar

3. Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA, et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care. 2010 May;33(5):1090-6. DOI: 10.2337/dc09194110.2337/dc091941Open DOISearch in Google Scholar

4. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000 Aug 12;321(7258):405-12. DOI: 10.1136/bmj.321.7258.40510.1136/bmj.321.7258.4052745410938048Open DOISearch in Google Scholar

5. Gillett MJ. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327-1334. Clin Biochem Rev. 2009 Nov;30(4):197-200.Search in Google Scholar

6. Larsson A, Greig-Pylypczuk R, Huisman A. The state of point-of-care testing: a European perspective. Ups J Med Sci. 2015 Mar;120(1):1-10. DOI: 10.3109/03009734.2015.100634710.3109/03009734.2015.1006347438900225622619Open DOISearch in Google Scholar

7. Portero McLellan KC, Wyne K, Villagomez ET, Hsueh WA. Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus. Ther Clin Risk Manag. 2014 10:173-88.10.2147/TCRM.S39564396416824672242Search in Google Scholar

8. Saldarriaga EM, Vodicka E, La Rosa S, Valderrama M, Garcia PJ. Point-of-Care Testing for Anemia, Diabetes, and Hypertension: A Pharmacy-Based Model in Lima, Peru. Ann Glob Health. 2017 Mar Apr;83(2):394-404. DOI: 10.1016/j.aogh.2017.03.51410.1016/j.aogh.2017.03.51428619417Search in Google Scholar

9. American Diabetes Association. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S55-S64. DOI: 10.2337/dc18-S00610.2337/dc18-S00629222377Open DOISearch in Google Scholar

10. Bergenstal RM, Gavin JR, 3rd, Global Consensus Conference on Glucose Monitoring P. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med. 2005 Sep;118(Suppl 9A):1S-6S. DOI: 10.1016/j.amjmed.2005.07.05510.1016/j.amjmed.2005.07.05516224936Search in Google Scholar

11. Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011 Feb;34(2):262-7. DOI: 10.2337/dc10-173210.2337/dc10-1732302433121270183Open DOISearch in Google Scholar

12. Virdi N, Daskiran M, Nigam S, Kozma C, Raja P. The association of self-monitoring of blood glucose use with medication adherence and glycemic control in patients with type 2 diabetes initiating non-insulin treatment. Diabetes Technol Ther. 2012 Sep;14(9):790-8. DOI: 10.1089/dia.2012.004710.1089/dia.2012.004722775240Search in Google Scholar

13. Grant RW, Huang ES, Wexler DJ, Laiteerapong N, Warton ME, Moffet HH, et al. Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 1;21(2):e119-29.Search in Google Scholar

14. Rajendran R, Rayman G. Point-of-care blood glucose testing for diabetes care in hospitalized patients: an evidence-based review. J Diabetes Sci Technol. 2014 Nov;8(6):1081-90. DOI: 10.1177/193229681453894010.1177/1932296814538940445548225355711Open DOISearch in Google Scholar

15. ISO 15197. In vitro diagnostic test systems Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. 2013. https://www.iso.org/standard/54976.htmlSearch in Google Scholar

16. Food and Drug Administration. Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use 2016. https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM380327.pdfSearch in Google Scholar

17. Food and Drug Administration. Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use 2016. https://www.fda.gov/downloads/ucm380325.pdfSearch in Google Scholar

18. Ekhlaspour L, Mondesir D, Lautsch N, Balliro C, Hillard M, Magyar K, et al. Comparative Accuracy of 17 Point-of-Care Glucose Meters. J Diabetes Sci Technol. 2017 May;11(3):558-66. DOI: 10.1177/193229681667223710.1177/1932296816672237550541527697848Open DOISearch in Google Scholar

19. Klonoff DC, Parkes JL, Kovatchev BP, Kerr D, Bevier WC, Brazg RL, et al. Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors. Diabetes Care. 2018 Aug;41(8):1681-8. DOI: 10.2337/dc17-196010.2337/dc17-196029898901Search in Google Scholar

20. Rebel A, Rice MA, Fahy BG. Accuracy of point-of-care glucose measurements. J Diabetes Sci Technol. 2012 Mar 1;6(2):396-411. DOI: 10.1177/19322968120060022810.1177/193229681200600228338078622538154Open DOISearch in Google Scholar

21. American Diabetes Association. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S144-S51. DOI: 10.2337/dc18-S01410.2337/dc18-S01429222385Open DOISearch in Google Scholar

22. Joseph JI, Hipszer B, Mraovic B, Chervoneva I, Joseph M, Grunwald Z. Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol. 2009 Nov 1;3(6):1309-18. DOI: 10.1177/19322968090030061110.1177/193229680900300611278703120144385Open DOISearch in Google Scholar

23. Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S. The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol Ther. 2015 Nov;17(11):787-94. DOI: 10.1089/dia.2014.037810.1089/dia.2014.0378464972526171659Open DOISearch in Google Scholar

24. Food and Drug Administration. iPro2 Continuous Glucose Monitoring (CGM) System 2016. https://www.accessdata.fda.gov/cdrh_docs/pdf15/P150029B.pdfSearch in Google Scholar

25. Food and Drug Administration. Freestyle Libre Pro Flash Glucose Monitoring System 2016. https://www.accessdata.fda.gov/cdrh_docs/pdf15/P150021B.pdfSearch in Google Scholar

26. Nakamura K, Balo A. The Accuracy and Efficacy of the Dexcom G4 Platinum Continuous Glucose Monitoring System. J Diabetes Sci Technol. 2015 Mar 23;9(5):1021-6. DOI: 10.1177/193229681557781210.1177/1932296815577812466733525802469Search in Google Scholar

27. Food and Drug Administration Advisory Panel Votes to Recommend Non-Adjunctive Use of Dexcom G5 Mobile CGM. Diabetes Technol Ther. 2016 Aug;18(8):512-6. DOI: 10.1089/dia.2016.07252.mr10.1089/dia.2016.07252.mr27472488Search in Google Scholar

28. Gomez AM, Henao Carrillo DC, Munoz Velandia OM. Devices for continuous monitoring of glucose: update in technology. Med Devices (Auckl). 2017 10:215-24. DOI: 10.2147/MDER.S11012110.2147/MDER.S110121560245628979168Search in Google Scholar

29. Thabit H, Leelarathna L, Wilinska ME, Elleri D, Allen JM, Lubina-Solomon A, et al. Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions. Diabetes Technol Ther. 2015 Nov;17(11):801-7. DOI: 10.1089/dia.2015.006210.1089/dia.2015.0062Open DOISearch in Google Scholar

30. Boscari F, Galasso S, Acciaroli G, Facchinetti A, Marescotti MC, Avogaro A, et al. Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile. Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):425-7. DOI: 10.1016/j.numecd.2018.01.00310.1016/j.numecd.2018.01.003Open DOISearch in Google Scholar

31. Stone MP, Agrawal P, Chen X, Liu M, Shin J, Cordero TL, et al. Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch. Diabetes Technol Ther. 2018 Oct;20(10):689-92. DOI: 10.1089/dia.2018.020210.1089/dia.2018.0202Search in Google Scholar

32. Foster NC, Miller KM, Tamborlane WV, Bergenstal RM, Beck RW, Network TDEC. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections. Diabetes Care. 2016 Jun;39(6):e81-2. DOI: 10.2337/dc16-020710.2337/dc16-0207Open DOISearch in Google Scholar

33. Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. JAMA. 2017 Jan 24;317(4):371-8. DOI: 10.1001/jama.2016.1997510.1001/jama.2016.19975Search in Google Scholar

34. Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, et al. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA. 2017 Jan 24;317(4):379-87. DOI: 10.1001/jama.2016.1997610.1001/jama.2016.19976Open DOISearch in Google Scholar

35. Jamiolkowska M, Jamiolkowska I, Luczynski W, Tolwinska J, Bossowski A, Glowinska Olszewska B. Impact of Real-Time Continuous Glucose Monitoring Use on Glucose Variability and Endothelial Function in Adolescents with Type 1 Diabetes: New Technology-New Possibility to Decrease Cardiovascular Risk? J Diabetes Res. 2016 2016:4385312.10.1155/2016/4385312Search in Google Scholar

36. Gomez AM, Alfonso-Cristancho R, Orozco JJ, Lynch PM, Prieto D, Saunders R, et al. Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia. Endocrinol Nutr. 2016 Nov;63(9):466-74. DOI: 10.1016/j.endonu.2016.05.01110.1016/j.endonu.2016.05.011Open DOISearch in Google Scholar

37. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kroger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016 Nov 5;388(10057):2254-63. DOI: 10.1016/S0140-6736(16)31535-510.1016/S0140-6736(16)31535-5Open DOISearch in Google Scholar

38. Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017 Dec;40(12):1631-40. DOI: 10.2337/dc17-160010.2337/dc17-1600646716529162583Open DOISearch in Google Scholar

39. Adolfsson P, Parkin CG, Thomas A, Krinelke LG. Selecting the Appropriate Continuous Glucose Monitoring System a Practical Approach. Eur Endocrinol. 2018 Apr;14(1):24-9. DOI: 10.17925/EE.2018.14.1.2410.17925/EE.2018.14.1.24595459129922348Search in Google Scholar

40. DuBose JJ, Inaba K, Branco BC, Barmparas G, Lam L, Teixeira PG, et al. Discrepancies between capillary glucose measurements and traditional laboratory assessments in both shock and non-shock states after trauma. J Surg Res. 2012 Dec;178(2):820-6. DOI: 10.1016/j.jss.2012.04.00310.1016/j.jss.2012.04.00322626561Open DOISearch in Google Scholar

41. Ellis MF, Benjamin K, Cornell M, Decker K, Farrell D, McGugan L, et al. Suitability of capillary blood glucose analysis in patients receiving vasopressors. Am J Crit Care. 2013 Sep;22(5):423-9. DOI: 10.4037/ajcc201369210.4037/ajcc2013692432483223996422Open DOISearch in Google Scholar

42. Boom DT, Sechterberger MK, Rijkenberg S, Kreder S, Bosman RJ, Wester JP, et al. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial. Crit Care. 2014 Aug 20;18(4):453. DOI: 10.1186/s13054-014-0453-910.1186/s13054-014-0453-9416187525139609Open DOISearch in Google Scholar

43. Bochicchio GV, Hipszer BR, Magee MF, Bergenstal RM, Furnary AP, Gulino AM, et al. Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients. J Diabetes Sci Technol. 2015 Jul;9(4):739-50. DOI: 10.1177/193229681558793910.1177/1932296815587939452565026033922Open DOISearch in Google Scholar

44. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, et al. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand. 2009 Jan;53(1):66-71. DOI: 10.1111/j.1399-6576.2008.01799.x10.1111/j.1399-6576.2008.01799.x19032568Open DOISearch in Google Scholar

45. Munekage M, Yatabe T, Sakaguchi M, Kitagawa H, Tamura T, Namikawa T, et al. Comparison of subcutaneous and intravenous continuous glucose monitoring accuracy in an operating room and an intensive care unit. J Artif Organs. 2016 Jun;19(2):159-66. DOI: 10.1007/s10047-015-0877-210.1007/s10047-015-0877-226721825Open DOISearch in Google Scholar

46. Shephard M, Shephard A, McAteer B, Regnier T, Barancek K. Results from 15years of quality surveillance for a National Indigenous Point-of-Care Testing Program for diabetes. Clin Biochem. 2017 Dec;50(18):1159-63. DOI: 10.1016/j.clinbiochem.2017.07.00710.1016/j.clinbiochem.2017.07.00728734906Search in Google Scholar

47. Biethman RK, Pandarakalam C, Garcia MN, Whitener S, Hildebolt CF. Screening for Diabetes in a Dental School Clinic to Assess Interprofessional Communication Between Physicians and Dental Students. J Dent Educ. 2017 Sep;81(9):1062-7. DOI: 10.21815/JDE.017.05910.21815/JDE.017.05928864787Search in Google Scholar

48. Whitley HP, Hanson C, Parton JM. Systematic Diabetes Screening Using Point-of-Care HbA1c Testing Facilitates Identification of Prediabetes. Ann Fam Med. 2017 Mar;15(2):162-4. DOI: 10.1370/afm.203510.1370/afm.2035534823528289117Open DOISearch in Google Scholar

49. Paknikar S, Sarmah R, Sivaganeshan L, Welke A, Rizzo A, Larson K, et al. Long-Term Performance of Point-of-Care Hemoglobin A1c Assays. J Diabetes Sci Technol. 2016 Nov;10(6):1308-15. DOI: 10.1177/193229681664536210.1177/1932296816645362509432027113451Open DOISearch in Google Scholar

50. Whitley HP, Yong EV, Rasinen C. Selecting an A1C Point-of-Care Instrument. Diabetes Spectr. 2015 Aug;28(3):201-8. DOI: 10.2337/diaspect.28.3.20110.2337/diaspect.28.3.201453663926300614Search in Google Scholar

51. National Glycohemoglobin Standardization Program homepage http://www.ngsp.org.Search in Google Scholar

52. Ferenczi A, Reddy K, Lorber DL. Effect of immediate hemoglobin A1c results on treatment decisions in office practice. Endocr Pract. 2001 Mar-Apr;7(2):85-8. DOI: 10.4158/EP.7.2.8510.4158/EP.7.2.8511421550Open DOISearch in Google Scholar

53. Zhou R, Wang W, Song ZX, Tong Q, Wang QT. Evaluation of a new hemoglobin A1c analyzer for point-of-care testing. J Clin Lab Anal. 2018 Jan; 32(1) DOI: 10.1002/jcla.2217210.1002/jcla.22172681702828220976Open DOISearch in Google Scholar

54. Bergenstal RM, Gal RL, Connor CG, Gubitosi-Klug R, Kruger D, Olson BA, et al. Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels. Ann Intern Med. 2017 Jul 18;167(2):95-102. DOI: 10.7326/M16-259610.7326/M16-259628605777Open DOISearch in Google Scholar

55. Lim S, Yu HJ, Lee S, Park H, Kwon MJ, Woo HY. Evaluation of the URiSCAN 2 ACR Strip to estimate the urine albumin/creatinine ratios. J Clin Lab Anal. 2017 Mar;32(3):1-6.10.1002/jcla.22289681687428649724Search in Google Scholar